Hang Seng Index
Sinopharm Group
China's largest pharmaceutical distributor, a state firm in drug wholesale, retail pharmacy, and medical device distribution. Hang Seng Index constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
1099.HK Updated Jul 11, 2026 2 AI consumers
Annual return · 2026-07-10'21-5.2%'22+15.8%'23+10.8%'24+4.5%'25+5.7%YTD-15.8%
Money in ▸·
Sinopharm Groupapprox. CN¥599.0B
▸ Money out·
Financials & Segments
- Total revenue · approx. CN¥599.0B (FY2023)
- Segments · Pharmaceutical distribution · Retail pharmacy · Medical devices
Revenue from
No refined links yet.
Pays to
No refined links yet.